MacuMira
Introducing MacuMira
Low Vision | BC is excited to introduce MacuMira, Canada’s first and only clinically proven treatment for dry age-related macular degeneration (AMD). This breakthrough treatment is also approved by Health Canada. Dry AMD is a prevalent and serious eye condition affecting over 2.5 million Canadians, gradually impairing vision and quality of life. As part of our commitment to delivering innovative eye care, we’re proud to offer this groundbreaking treatment to our patients.
MacuMira is a major breakthrough in managing dry AMD. It offers new hope for those looking to protect and preserve their vision.
Enhance Your Vision and Reclaim Independence
Imagine what you will be able to do again with improved visual performance. Start your journey towards more independence today. Call us to book your appointment and discover the benefits of MacuMira!
How does MacuMira work?
MacuMira uses gentle, painless microcurrent therapy applied over closed eyelids to stimulate retinal pigment epithelium (RPE) cells. This therapy enhances cellular function and helps clear macular waste, making it easier for you to see.
Benefits of MacuMira?
- Proven Results: Patients with dry AMD have experienced improved vision and an enhanced quality of life. Many have reported noticeable improvements in their vision, enabling them to enjoy daily activities with greater ease.
- Safe & Comfortable: Designed with patient comfort in mind The treatment is gentle and painless, performed conveniently in the calm and professional setting of our office, ensuring a stress-free experience.
- Convenient: The treatment plan is tailored to fit your busy lifestyle. It involves four 32-minute sessions over the course of 10 days, followed by a simple 32-minute maintenance session every 2-3 months. This efficient schedule minimizes disruption to your routine while prioritizing your eye health.
In Canada, age-related macular degeneration (AMD) is a leading cause of vision loss, affecting an estimated 2.5 million people – macumira.com